Archive →
Daily Morning Briefing

Monday, 11 May 2026

Trump rejects Iran's reply as "totally unacceptable" · Brent jumps over the weekend · Asia mixed, Nikkei choppy on Nintendo · UK Catherine West deadline today on Starmer · Magyar takes power in Budapest · US April CPI tomorrow
Europe/Rome 06:00 · Oil bid, gold bid · S&P/Nasdaq enter the week at records · CPI Tue · Trump–Xi Thu/Fri · Powell out Fri

Top of the morning

Markets snapshot — Monday morning open levels

US/European cash markets reference Friday 8 May close; Asia values are this morning's session prints; oil reflects the Sunday electronic re-open after Trump's "totally unacceptable" line. Numbers are rounded; intra-morning moves will modify.

InstrumentLastChange / context
S&P 500 (Fri close)7,399+0.8% Fri · +2.3% wk · record close
Nasdaq Composite (Fri close)26,247+1.7% Fri · +4.5% wk · record close
Dow Jones (Fri close)49,609~flat Fri · ~+0.2% wk
Nikkei 225 (today)marginally lower · Nintendo −5.54%
Topix (today)+0.19%
Hang Seng (today)−0.48% on Iran tone
CSI 300 (today)+0.58% · CPI/PPI overshoot
STOXX 600 (Fri close)~623modest weekly gain
FTSE 100 (Fri close)−1.26% wk · UK politics
DAX (Fri close)~24,920+0.19% wk
FTSE MIB (Fri close)+2.16% wk · best in Europe
US 10y Treasury4.38%~−3bp Fri · two-week low
UK 30y gilt~5.54–5.58%eased on Starmer's vow to stay
EUR/USD~1.17483-week high · hawkish ECB pricing
GBP/USD~1.36firmer · vs EUR ~0.864
Brent crude (Sun re-open)~$104.5+3.2% Sun · Trump rejects Iran reply
WTI crude (Sun re-open)~$98.5+3.2% Sun · Hormuz premium back
Gold (XAU)~$4,720+>2% wk · still bid as hedge

Geopolitics & today's watch

The headline geopolitics shift overnight is the unwinding of last week's softer Iran-diplomacy assumption. Tehran's 14-point reply made the politically obvious moves — sovereignty over the Strait of Hormuz framed as non-negotiable, a 30-day rather than two-month resolution timeline, willingness to ship out some highly enriched uranium but a hard refusal to dismantle enrichment infrastructure — and Trump rejected the package on Sunday in unusually blunt terms. The market's first reaction was the obvious one: Brent up about 3.2% on the electronic re-open, gold holding above $4,720, equity futures softer on the energy passthrough. The supportive thread is still there — the Pakistan/Iran negotiation for more Qatari LNG via Hormuz is a tacit signal that operational corridors remain viable — but the diplomatic path has narrowed materially. The binding signal this week is whether Tehran returns to the table with a softer line within the 30-day window or whether the next escalation is operational rather than rhetorical. Drone activity around Qatari shipping over the weekend and Aramco's CEO flagging a long disruption point to the latter as the higher-probability path.

The second story is the European political reset. Magyar's swearing-in is a clean dovish event for CEE risk premia and a fresh complication for the Trump White House's Visegrád calculus. Within hours of taking office he has confronted President Sulyok and demanded his resignation by 31 May, and the news this morning that a Polish fugitive minister fled Hungary as Orbán was being pushed out shows how quickly the regional politics will be relitigated. Add the UK's Catherine West Monday deadline on Starmer, the Reform UK sweep that produced it, Australia's One Nation winning its first lower-house seat in Farrer, and the picture for the week is of populism remaining the dominant flow in European-and-Anglosphere politics while the institutional centre regains a single capital (Budapest) on the back of voter fatigue with that same flow. For long-dated paper the term-premium story stays alive; for European equity the political backdrop continues to favour Italy and Spain over the UK and France in relative terms.

Two adjacent threads to track: Venezuela's Maduro is in The Hague today for the Essequibo land dispute against Guyana — a low-probability but high-impact South-American flashpoint that has been quietly building. And Microsoft's African data-centre payment dispute is a small but telling sign that the AI-infrastructure buildout is hitting counterparty friction outside the OECD core, which has implications for the AI-capex story dominating equity leadership.

Central banks & the rate-cut narrative

Tomorrow's US CPI is the macro event of the week, with consensus at +0.6% m/m headline / +3.7% y/y and core at +0.3% / +2.7%. The headline number is loaded with energy passthrough — exactly the pressure that Sunday's oil move will compound — and the core print is the cleaner read on whether services disinflation is still on track. Goldman has pushed the first Fed cut to December, then March; a downside core surprise would put September back into play, while a hot print pushes the next cut into early 2027. The complication is the Fed-chair handover: Powell's term ends Friday 15 May, the Senate is expected to vote on Kevin Warsh's nomination this week, and Goolsbee has explicitly said all options are on the table. Waller flagged on Friday that the regional Feds will centralise some functions — a structural reorganisation signal layered on top of the cyclical decision. Net: tomorrow's print lands into a market priced for soft-landing equity multiples and a Fed that may have a new chair and a new direction by Friday.

In Europe the picture is mirrored but cleaner. With money markets pricing better than 75% odds of an 11 June ECB hike and more than 50bp of tightening through year-end, the hawkish side of the council (Nagel, Kazimir, Escrivá) is getting validated. Lagarde's Friday "torn between too early and too late" line is the candid version. EUR/USD at ~1.1748 is the price-action confirmation. The BoE post-decision tone is what GBP at ~1.36 is digesting, with UK politics now layered as the local risk; with Starmer staying for now, the immediate fiscal-loosening tail is priced down, but a Catherine West challenge today would re-introduce it. Hungary's central bank had been signalling a possible June rate move on a strong forint; Magyar's ascent makes that a cleaner political call. For long-duration healthcare equities and biotech the practical takeaway is unchanged: the rate path is the dominant input, and tomorrow is the next inflection.

Big Tech, AI & corporates

The dominant tech story this morning is Bloomberg's framing of Alphabet as on track to become the world's most valuable company on the back of recent AI wins — a complete inversion of the late-2025 narrative that had Google losing the AI race. The mechanics are Gemini traction, the Isomorphic Labs $2bn-plus raise, and the underlying point that Google's distribution surface (Search, Android, Workspace, Cloud) is finally being seen as defensible at the model layer rather than disrupted by it. Around the edges: Microsoft's African data-centre stumble is a counterparty-risk reminder that AI capex is real-world infrastructure; the Bloomberg "Big Take" on AST SpaceMobile (the SpaceX rival up roughly 6,000% on online-mob momentum) is the speculative bookend; and the Musk–Altman OpenAI courtroom drama continues to surface management-style detail without changing the underlying balance of power. ByteDance reportedly raising AI-infrastructure capex by 25% sits alongside the China decoupling thread.

Around the deal tape: Apollo and Blackstone are reportedly weighing a $35bn financing for Broadcom — the kind of mandate that is bringing banks back into the conversation as private debt shrinks. Vodafone is reportedly weighing a partial transfer of its India unit stake. Frontier is consolidating Spirit's collapsed routes. Drake brought in new investors at Venice FC. Citigroup hired senior bankers in infrastructure and South Africa. Bloomberg flags that OPTrust is going to court to recoup $80m from a Westbank tower. The Pulitzer Prizes 2026 went to Bloomberg News for Illustrated Reporting and Commentary — the trAPPed graphic investigation into India's digital arrests, an underappreciated EM-fintech risk surface that is now unambiguously in the institutional consciousness.

Health & science (worth a glance)

The main near-term watch is the cruise-ship hantavirus cluster, now in evacuation in the Canary Islands. The relevant clinical framing remains: high case fatality in severe pulmonary syndrome (~30–40%), very low person-to-person transmissibility, no plausible pandemic-tail mechanism. Bloomberg Businessweek's framing remains the more useful one — this is a travel-medicine and cross-border detection-gap story rather than an outbreak in the public-health sense — and Italian port-of-entry surveillance is the relevant operational angle for European clinicians and reinsurers.

On the workforce side, the AY 2026–27 residency and fellowship pipeline for the 1 July start is still functionally locked even after the partial walk-back of the overseas-physician immigration crackdown; the service-line impact for autumn is already determined. The DOJ case against UCLA medical school is the longer-arc story to watch on DEI in medical education and its downstream effects on residency funding. On therapeutics, Novo's Ozempic India price cut is materially boosting volumes — a clean EM-pharma volume-vs-price read; combined with persistent GLP-1 demand metrics into H2, the price/volume curve is firming up as a defensible thesis even after supply normalisation. On AI in clinical workflows, ambient documentation tooling continues to expand from primary care into specialist surfaces; Bloomberg Opinion's piece this morning on the anthropomorphisation of frontier models is a useful sociological signal for how patients will frame interactions with these tools over the next 12–18 months.

Week ahead (CET)